Nxstage Medical INC (NXTM) Stock Rose While Alpine Partners Vi LLC Has Lowered Stake

October 11, 2018 - By Adrian Erickson

Nxstage Medical, Inc. (NASDAQ:NXTM) LogoInvestors sentiment decreased to 1.08 in 2018 Q2. Its down 0.02, from 1.1 in 2018Q1. It worsened, as 17 investors sold NXTM shares while 45 reduced holdings. 29 funds opened positions while 38 raised stakes. 48.01 million shares or 0.33% less from 48.16 million shares in 2018Q1 were reported. The New York-based Falcon Edge Capital Lp has invested 3.11% in Nxstage Medical, Inc. (NASDAQ:NXTM). Yakira accumulated 61,721 shares. Pnc Fincl Svcs reported 141 shares stake. Glazer Cap Ltd holds 0.02% of its portfolio in Nxstage Medical, Inc. (NASDAQ:NXTM) for 7,762 shares. Kopp Investment Advisors has 2.37% invested in Nxstage Medical, Inc. (NASDAQ:NXTM) for 93,888 shares. Commonwealth Of Pennsylvania School Empls Retrmt Systems holds 0.15% or 409,468 shares in its portfolio. California Pub Employees Retirement holds 96,138 shares. State Street, Massachusetts-based fund reported 1.53M shares. Moab Cap Ltd Co holds 226,363 shares or 1.53% of its portfolio. Moreover, Magnetar Financial Ltd has 1.65% invested in Nxstage Medical, Inc. (NASDAQ:NXTM) for 3.07M shares. Ameritas Partners Incorporated holds 0.01% or 5,498 shares. 306,119 were reported by Dafna Cap Mngmt. Moreover, Tokio Marine Asset Mngmt Ltd has 0.19% invested in Nxstage Medical, Inc. (NASDAQ:NXTM) for 37,200 shares. Aqr Management Lc has invested 0% in Nxstage Medical, Inc. (NASDAQ:NXTM). Tig Advisors Ltd Co accumulated 3.49 million shares.

Alpine Partners Vi Llc decreased its stake in Nxstage Medical Inc (NXTM) by 36.02% based on its latest 2018Q2 regulatory filing with the SEC. Alpine Partners Vi Llc sold 177,200 shares as the company’s stock rose 0.57% with the market. The institutional investor held 314,800 shares of the health care company at the end of 2018Q2, valued at $8.78 million, down from 492,000 at the end of the previous reported quarter. Alpine Partners Vi Llc who had been investing in Nxstage Medical Inc for a number of months, seems to be less bullish one the $1.85 billion market cap company. The stock increased 2.22% or $0.61 during the last trading session, reaching $28.13. About 128,871 shares traded. Nxstage Medical, Inc. (NASDAQ:NXTM) has risen 1.72% since October 11, 2017 and is uptrending. It has underperformed by 13.90% the S&P500.

Another recent and important Nxstage Medical, Inc. (NASDAQ:NXTM) news was published by Stockhouse.com which published an article titled: “New Report Highlighting Lack of Patient Choice for Thousands of UK Kidney Patients Calls for Change” on October 09, 2018.

Nxstage Medical, Inc. (NASDAQ:NXTM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>